Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Development of new worm egg counting kits WATERBURY, Conn., June 7 /PRNewswire-FirstCall/ -- DiaSys Corporation's (OTC:DYXC) (BULLETIN BOARD: DYXC) wholly owned subsidiary, DiaSys Europe...
WATERBURY, Conn., Dec. 18 /PRNewswire-FirstCall/ -- DiaSys Corporation (OTC:DYXC) (BULLETIN BOARD: DYXC) a global healthcare products company, announced today that it has signed a five year...
WATERBURY, Conn., Nov. 20 /PRNewswire-FirstCall/ -- DiaSys Corporation (OTC:DYXC) (BULLETIN BOARD: DYXC) On November 15, 2006, DiaSys Corporation (the "Company") filed its Annual Report on Form...
WATERBURY, Conn., Nov. 20 /PRNewswire-FirstCall/ -- DiaSys Corporation (OTC:DYXC) (BULLETIN BOARD: DYXC) today announced the product introduction of Parasep SF, a solvent free fecal parasite...
Net Loss Reduced Seventy Six Percent WATERBURY, Conn., Aug. 17 /PRNewswire-FirstCall/ -- DiaSys Corporation (OTC:DYXC) (BULLETIN BOARD: DYXC) , a global healthcare products company, today...
WATERBURY, Conn., April 13 /PRNewswire-FirstCall/ -- DiaSys Corporation (OTC:DYXC) (BULLETIN BOARD: DYXC) a global healthcare products company, announced today that it has signed a new...
WATERBURY, Conn., March 28 /PRNewswire-FirstCall/ -- DiaSys Corporation (OTC:DYXC) (BULLETIN BOARD: DYXC) a global healthcare products company, announced today that it has signed a new...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
| 26 | 8.0E-5 | 400 | 2.0E-5 | 0.0001 | 2.0E-5 | 170 | 0.0001 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0002 | 1.0E-6 | 672 | 0.00013317 | CS |
| 156 | 0 | 0 | 0.0001 | 0.001 | 1.0E-6 | 2697 | 7.349E-5 | CS |
| 260 | 9.9E-5 | 9900 | 1.0E-6 | 0.001 | 1.0E-6 | 21611 | 0.00019253 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
